← FDA Drug Approvals (Drugs@FDA)

JAKAFI

NDA · New Drug Application · Sponsor: INCYTE CORP · Approved 2011-11-16

Drug application

FDA Application #

NDA202192

Application type

New Drug Application

Brand name

JAKAFI

Generic name

RUXOLITINIB

Active ingredients

RUXOLITINIB PHOSPHATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

INCYTE CORP

Manufacturer

Incyte Corporation

First approval

2011-11-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown